🇺🇸 FDA
Pipeline program

Cytovir-ADV

CM-2011-02

Phase 2 mab completed

Quick answer

Cytovir-ADV for ADV Infection Post Allo-HSCT is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
ADV Infection Post Allo-HSCT
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials